Furthermore, GLP-1 RAs not only improve glycaemia but also provide additional benefits such as body weight reduction and protective effects against cardiovascular disease and diabetic kidney disease (DKD), and metabolic dysfunction-associated steatotic liver disease (MASLD)[5–7]. The gene discussed is GCG; the disease is cardiovascular disorder.